WEEKLY TRENDSETTER ( NOV 14,2025)
| 2025 | OCT 31 | NOV 7 | Ch % |
| NIFTY | 25722 | 25492 | -0.89 |
| BANK NIFTY | 57776 | 57876 | +0.17 |
| USD/INR | 88.77 | 88.68 | -0.10 |
MARKET REVIEW-The week saw continuation of selling pressure though there were pockets of strength where discerning investors are entering. The IPO market is in full swing and the entrepreneur spirit of India is in full display. While listing gains have not been up to investor expectations, in the years to come a few of them are certain to give stellar returns. For the coming week the Bihar election results could be a trigger for any sharp swing. The results are expected on Nov 14.
BACK TO RESULT SEASON
Sept quarter results are trickling in. Let’s explore some of them to get cues of where the stocks could be heading.
Rs in cr, Bracket indicates ch in % against Sept,24 quarter. Loss as in absolute number
| Company | Revenue | Net profit |
| Aegis Vopak | 161(+31) | 48(+188) |
| Tatva Chintan | 116(+43) | 9(-1) |
| Laurus Labs | 1653(+35) | 194(+977) |
| Finolex Inds | 859(+3) | 114(+192) |
Aegis Vopak (260) –The company operates a strategic network of 20 state-of-the-art tank terminals located at India’s major ports, Including the nation’s largest integrated Bulk Liquid and LPG Terminals in Pipavav, Kandla. Another terminal is coming in Mangalore. The terminals optimize product logistics by providing connectivity to jetties, pipelines, railways, and roads. This ensures the quick and reliable movement of vital products from ship to shore. The company went public in May 2025 at an issue price of Rs 235 per share. The prospects are bright as it is the largest Indian third-party owner and operator of tank storage terminals. With an EPS of 0.45 for the quarter the stock looks well priced. The stock is clearly for long term patient investors.
Tatva Chintan (1500)- The company, which is into manufacture of speciality chemicals which went public in June 2021 at a price of Rs 1083. Post the IPO the performance could not match the steep premium at which the issue came. With a string of poor quarters, the stock touched a low of Rs 600 early this year. The last 2 quarters have raised hopes of a revival. However, with an EPS of Rs 6 for the 6 months of the current year the stock seems to have run ahead and at current levels looks well priced.
Laurus Labs (982)-The company has been the revival story of the year. After robust performance till FY 22, it went into a sluggish phase. The performance till FY22 was largely due to surge in demand for antiretroviral (ARV) drugs during the pandemic, where Laurus, armed with pre-pandemic manufacturing expansion, capitalized on the opportunity. However, post pandemic there was a slump and the company re-invented itself. Recognizing the risks of a pandemic-dependent portfolio, the company launched a Rs 3,200 cr capex cycle between FY22-FY25, targeting CDMO (contract development and manufacturing organization) services and emerging technologies such as cell and gene therapy. Approximately 74% of this capex was channeled toward APIs and CDMO, with the rest to drug product capabilities. The fruits of this investment is getting reaped as the last 3 quarters have seen block buster results. With an EPS of Rs 6.6 for the 6 months of the current year the stock has raced ahead. At current levels it appears to be well priced.
Finolex Inds-(185) The company has a strong presence in agricultural, plumbing and sanitation pipes and fittings. The last few quarters have seen some sluggish performance. However, some revival is seen in the Sept quarter as margins have improved despite the topline remaining flat. The stock price has also seen a sharp correction in the past one year from levels of 350. With an expected EPS of Rs 8 for the current year the stock looks like an accumulation candidate though technically levels of 165-170 would be ideal.
NIFTY –The index failed to sustain above 25750 and the selling pressure took it down to 25300 before some short covering resulted in a closing little below 25500.The recovery was largely due to the banking counters which aided in paring of some losses. The range for the coming week is expected to be be 25400 -25700 and the previous week ‘s low of 25300 will be critical.
BANK NIFTY-The index closed marginally in the green and as has been the case in most of the moves the private sector banks were the ones to push up the index while the PSU peers were relative outperformers. A range of 57200-58000 could be expected. It’s still near the all-time high of 58577.
STOCK PICKS
ICICI Lombard (2020)-The stock consolidated in the 1900-2000 range and now looks to extend the gains. Ideal level for entry would be 1990-2000 and accumulation can be considered for a possible target of 2150 in the coming weeks.
Adani Port (1448)-The stock has repeatedly seen resistance around 1500 levels since the last few months. However, buying at around 1300-1350 has seen it making steady gains. Accumulation at dips could be considered for a possible target of 1500.
Wishing all readers a good week ahead!
Note: Any queries /clarifications may be addressed to stockmasala@gmail.com .
Krish Subramanyam